Starpharma Holdings Limited (SPL.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.7950-0.1050 (-5.53%)
At close: 4:11PM AEDT
| Previous close | 1.9000 |
| Open | 1.8700 |
| Bid | 1.7900 x 334700 |
| Ask | 1.7950 x 1317400 |
| Day's range | 1.7600 - 1.8900 |
| 52-week range | 0.6150 - 2.5200 |
| Volume | 1,850,550 |
| Avg. volume | 1,118,679 |
| Market cap | 728.842M |
| Beta (5Y monthly) | 1.32 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0510 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 25 Mar 1988 |
| 1y target est | 1.44 |
- Simply Wall St.
Are Institutions Heavily Invested In Starpharma Holdings Limited's (ASX:SPL) Shares?
The big shareholder groups in Starpharma Holdings Limited ( ASX:SPL ) have power over the company. Institutions often...
- PR Newswire
Starpharma signs DEP® ADC Research Agreement with MSD
Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that is has signed a Research Agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth NJ USA. Under the agreement, MSD will conduct a preclinical research evaluation of dendrimer based Antibody Drug Conjugates (ADCs) utilising Starpharma's proprietary DEP® technology.
- Simply Wall St.
If You Had Bought Starpharma Holdings (ASX:SPL) Shares Five Years Ago You'd Have Earned 119% Returns
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
© 2021 Verizon Media. All rights reserved.
